--- title: "Is Ajinomoto (TSE:2802) Turning Nutrition Science Into a Lasting Edge in Health-Focused Foods?" type: "News" locale: "en" url: "https://longbridge.com/en/news/292325660.md" description: "Ajinomoto and the University of Tokyo validated the ANPS-Day system, linking dietary data to biomarkers, strengthening its health-food positioning. Concurrently, the company completed a ¥49.3 billion share buyback. While innovation supports long-term growth narratives targeting ¥1.885 trillion revenue by 2029, near-term catalysts remain volume recovery and cost management. Analysts project fair values with mixed outlooks, citing risks from raw material inflation and demand weakness." datetime: "2026-07-10T13:08:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292325660.md) - [en](https://longbridge.com/en/news/292325660.md) - [zh-HK](https://longbridge.com/zh-HK/news/292325660.md) --- # Is Ajinomoto (TSE:2802) Turning Nutrition Science Into a Lasting Edge in Health-Focused Foods? - Ajinomoto Co., Inc. and the University of Tokyo recently reported that their jointly developed ANPS-Day system can assess a full day’s diet quality using biomarkers from healthy Japanese adults, marking a Japan-first link between real-world dietary data and 24-hour urine collection results. - This scientific validation strengthens Ajinomoto’s position in health-oriented food technologies, potentially enhancing the credibility and differentiation of its nutrition-focused products and services. - We’ll now examine how validation of the ANPS-Day full-day nutritional assessment system could influence Ajinomoto’s broader investment narrative and growth initiatives. We've uncovered the 43 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them. ## Ajinomoto Investment Narrative Recap To own Ajinomoto, you need to believe it can convert its food and amino science know-how into higher value, health-oriented products while managing cost and volume pressures in core foods. The ANPS-Day validation fits that story, but it does not materially change near term catalysts, which remain volume recovery after price hikes and execution on fixing underperforming frozen foods. Key risks still center on raw material cost inflation and ongoing demand weakness in several core geographies. Among recent announcements, the completion of the ¥49,368.79 million share buyback stands out next to ANPS-Day. While ANPS-Day reinforces Ajinomoto’s health and nutrition credentials, the buyback directly affects how existing earnings are spread across fewer shares and signals how management is using excess cash in the midst of margin pressures and turnaround efforts in Japan’s frozen foods business. Yet beneath the innovation story, investors should be aware that sustained volume weakness in key markets could still... Read the full narrative on Ajinomoto (it's free!) Ajinomoto’s narrative projects ¥1,885.0 billion revenue and ¥186.0 billion earnings by 2029. This requires 6.0% yearly revenue growth and about a ¥51.3 billion earnings increase from ¥134.7 billion today. Uncover how Ajinomoto's forecasts yield a ¥4932 fair value, a 14% downside to its current price. ## Exploring Other Perspectives TSE:2802 1-Year Stock Price Chart While ANPS Day points to innovation, the most cautious analysts still expected only about ¥1,886,000 million in revenue and ¥163,900 million in earnings by 2029, reminding you that views on Ajinomoto’s long term potential can differ sharply and may shift again as this new data filters into both the optimistic and more cautious cases. Explore 3 other fair value estimates on Ajinomoto - why the stock might be worth as much as 7% more than the current price! ## Decide For Yourself Don't just follow the ticker - dig into the data and build a conviction that's truly your own. - A great starting point for your Ajinomoto research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision. - Our free Ajinomoto research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ajinomoto's overall financial health at a glance. ## No Opportunity In Ajinomoto? Our top stock finds are flying under the radar-for now. Get in early: - Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow. - Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution. - The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### **New:** Manage All Your Stock Portfolios in One Place We've created the **ultimate portfolio companion** for stock investors, **and it's free.** • Connect an unlimited number of Portfolios and see your total in one currency • Be alerted to new Warning Signs or Risks via email or mobile • Track the Fair Value of your stocks Try a Demo Portfolio for Free ### Related Stocks - [2802.JP](https://longbridge.com/en/quote/2802.JP.md) ## Related News & Research - [Ajinomoto raises AI chip-film prices 30% as profit jumps 127%](https://longbridge.com/en/news/295303930.md) - [Ajinomoto: Double-digit sales and profit growth driven by strong electronic materials demand](https://longbridge.com/en/news/295066392.md) - [Ajinomoto: Record Q1 results and strong Functional Materials performance led to upward FY2026 guidance](https://longbridge.com/en/news/295065868.md) - [Ajinomoto to Dispose Treasury Shares for Executive Stock Incentive Plan](https://longbridge.com/en/news/294320627.md) - [Mooncake prices hiked by up to 20% on rising costs](https://longbridge.com/en/news/295627487.md)